Yingjie Hou

Tianjin, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 9 publications

Engineered haptoglobin β fusion protein targets myoglobin and ameliorates rhabdomyolysis-associated acute kidney injury.

Engineered haptoglobin β fusion protein targets myoglobin and ameliorates rhabdomyolysis-associated acute kidney injury.

Journal: EMBO molecular medicine

Published: October 09, 2025

Beyond CAR-T Cells: exploring CAR-NK, CAR-M, and CAR-γδ T strategies in solid tumor immunotherapy.

Beyond CAR-T Cells: exploring CAR-NK, CAR-M, and CAR-γδ T strategies in solid tumor immunotherapy.

Journal: Frontiers in immunology

Published: July 29, 2025

Regulating the GTP cyclohydrolase 1/tetrahydrobiopterin axis in the distal tubule inhibits ferroptosis and alleviates crush syndrome-related acute kidney injury in mice.

Regulating the GTP cyclohydrolase 1/tetrahydrobiopterin axis in the distal tubule inhibits ferroptosis and alleviates crush syndrome-related acute kidney injury in mice.

Journal: Cellular signalling

Published: July 13, 2025

Beyond Immunity: RIG-I as a Bifunctional Regulator of Cell Fate in Non-Infectious Diseases.

Beyond Immunity: RIG-I as a Bifunctional Regulator of Cell Fate in Non-Infectious Diseases.

Journal: Journal of molecular biology

Published: July 08, 2025

Construction of ubiquitination-related risk model for predicting prognosis in lung adenocarcinoma.

Construction of ubiquitination-related risk model for predicting prognosis in lung adenocarcinoma.

Journal: Scientific reports

Published: August 02, 2024

Rescue RM/CS-AKI by blocking strategy with one-dose anti-myoglobin RabMAb.

Rescue RM/CS-AKI by blocking strategy with one-dose anti-myoglobin RabMAb.

Journal: Nature communications

Published: June 24, 2024

Paving the way ahead: protocol optimization of mouse models in crush syndrome related acute kidney injury research.

Paving the way ahead: protocol optimization of mouse models in crush syndrome related acute kidney injury research.

Journal: Frontiers in pharmacology

Published: May 25, 2024

Rosmarinic acid plus deferasirox inhibits ferroptosis to alleviate crush syndrome-related AKI via Nrf2/Keap1 pathway.

Rosmarinic acid plus deferasirox inhibits ferroptosis to alleviate crush syndrome-related AKI via Nrf2/Keap1 pathway.

Journal: Phytomedicine : international journal of phytotherapy and phytopharmacology

Published: November 08, 2023

Protocol for identification and validation of 2'3'-cGAMP-binding proteins by photoaffinity probes.

Protocol for identification and validation of 2'3'-cGAMP-binding proteins by photoaffinity probes.

Journal: STAR protocols

Published: January 17, 2022

Showing 1-9 of 9

Last Updated: 09/26/2026